F1Exemption from charges in respect of listed medicines7C
1
No patient shall be liable to pay a charge under these Regulations in respect of the following medicines—
a
oseltamivir (marketed as Tamiflu);
b
zanamivir (marketed as Relenza),
in the circumstances set out in paragraph (2).
2
Those circumstances are that—
a
the Secretary of State has made arrangements for supplying the medicine to patients free of charge; or
b
the NHS body that is responsible for the arrangements under which the medicine is supplied has made arrangements, with the approval of the Secretary of State, for supplying the medicine to patients free of charge,
and the patient is supplied with the medicine under those arrangements.